Protalix BioTherapeutics
PLX
#8816
Rank
A$0.24 B
Marketcap
A$3.08
Share price
-0.68%
Change (1 day)
-23.02%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): A$11.65 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$61.84 Million. In 2024 the company made an earning of A$7.28 Million a decrease over its 2023 earnings that were of A$16.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$11.65 M60.06%
2024 A$7.28 M-55.62%
2023 A$16.41 M-199.05%
2022 -A$16.57 Million-40.38%
2021 -A$27.8 Million-732.31%
2020 A$4.39 M-130.53%
2019 -A$14.4 Million189.85%
2018 -A$4.97 Million-95.29%
2017 -A$0.11 Billion308.12%
2016 -A$25.85 Million-32.37%
2015 -A$38.22 Million10.11%
2014 -A$34.71 Million-7.59%
2013 -A$37.56 Million
2011 -A$43.5 Million-19.39%
2010 -A$53.96 Million20.87%
2009 -A$44.64 Million32.26%
2008 -A$33.75 Million-5.46%
2007 -A$35.7 Million
2004 -A$0.24 Million12.35%
2003 -A$0.21 Million-11.1%
2002 -A$0.24 Million-57.03%
2001 -A$0.54 Million1.03%
2000 -A$0.54 Million-53.22%
1999 -A$1.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.23 B 136,540.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.88 B 8,433.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.26 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.00 B 28,751.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel